Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Pancreatic Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07055568
What this trial is testing

A Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of Allogeneic iNKT Cell Infusion in Subjects With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 18
Testing effectiveness (Phase 2)Ended earlyNCT06024174
What this trial is testing

BMS-986466 With Adagrasib With or Without Cetuximab in Participants With Kirsten Rat Sarcoma Virus Glycine 12 to Cysteine (KRAS G12C)-Mutant Solid Tumors

Who this might be right for
Advanced Solid Tumors
Bristol-Myers Squibb 5
Testing effectiveness (Phase 2)Ended earlyNCT02431260
What this trial is testing

An Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced Malignancies

Who this might be right for
Solid Tumors and Hematologic Malignancy
Incyte Corporation 69
Testing effectiveness (Phase 2)Active Not RecruitingNCT05057013
What this trial is testing

A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours

Who this might be right for
Bladder CancerTriple Negative Breast CancerCastration-resistant Prostate Cancer+11 more
Cancer Research UK 81
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06888648
What this trial is testing

Personalized Tumor Neoantigen MRNA Therapy for Advanced Pancreatic Cancer.

Who this might be right for
Pancreatic Cancer MetastaticPancreatic Cancer Non-resectable
Zhejiang University 30
Testing effectiveness (Phase 2)WithdrawnNCT03432676
What this trial is testing

Epacadostat and Pembrolizumab in Treating Participants With Advanced Pancreatic Cancer

Who this might be right for
ATM Gene MutationDeleterious BRCA1 Gene MutationDeleterious BRCA2 Gene Mutation+7 more
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02301143
What this trial is testing

Phase 2 Nab® -Paclitaxel (Abraxane®) Plus Gemcitabine in Subjects With Locally Advanced Pancreatic Cancer (LAPC)

Who this might be right for
Pancreatic Neoplasms
Celgene 107
Testing effectiveness (Phase 2)Study completedNCT00633789
What this trial is testing

Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types

Who this might be right for
Advanced Non-small Cell Lung CancerTransitional Cell CarcinomaSoft Tissue Sarcoma+2 more
Bristol-Myers Squibb 597
Testing effectiveness (Phase 2)Study completedNCT00033384
What this trial is testing

CI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung Cancer

Who this might be right for
Breast CancerColorectal CancerLung Cancer+1 more
University of Alabama at Birmingham
Testing effectiveness (Phase 2)Study completedNCT00075647
What this trial is testing

CCI-779 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage II Pancreatic Cancer+2 more
National Cancer Institute (NCI) 40
Early research (Phase 1)UnknownNCT04707118
What this trial is testing

Ntraperitoneal Thermal Perfusion Combined With Chemotherapy Versus Chemotherapy

Who this might be right for
Advanced Pancreatic Cancer
Fudan University 106
Testing effectiveness (Phase 2)Study completedNCT03336216
What this trial is testing

Cabiralizumab Given With Nivolumab With and Without Chemotherapy in Patients With Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Cancer
Bristol-Myers Squibb 205
Testing effectiveness (Phase 2)WithdrawnNCT06398587
What this trial is testing

Onvansertib in Combination With Gemcitabine and Nab-paclitaxel for the Treatment of Patients With Locally-advanced, Unresectable, or Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Locally Advanced Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic Ductal AdenocarcinomaStage II Pancreatic Cancer AJCC v8+3 more
OHSU Knight Cancer Institute
Testing effectiveness (Phase 2)Looking for participantsNCT07627711
What this trial is testing

Dual-Target CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Unresectable Locally AdvancedMetastatic Disease
Beijing Biotech 42
Testing effectiveness (Phase 2)Ended earlyNCT03207867
What this trial is testing

NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma

Who this might be right for
NSCLC, Non Small Cell Lung CancerRCC, Renal Cell CancerPancreatic Cancer+7 more
Novartis Pharmaceuticals 315
Early research (Phase 1)Looking for participantsNCT05932862
What this trial is testing

XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Exelixis 429
Testing effectiveness (Phase 2)UnknownNCT01882946
What this trial is testing

Safety and Efficacy Study of DCVax-Direct in Solid Tumors

Who this might be right for
Locally Advanced TumorMetastatic Solid Tissue TumorsLiver Cancer+3 more
Northwest Biotherapeutics 60
Testing effectiveness (Phase 2)Looking for participantsNCT06387342
What this trial is testing

Namodenoson Treatment of Advanced Pancreatic Cancer

Who this might be right for
Pancreatic AdenocarcinomaPancreatic Cancer
Can-Fite BioPharma 20
Large-scale testing (Phase 3)Study completedNCT01926197
What this trial is testing

Phase 3 Study of FOLFIRINOX (mFFX) +/- SBRT in Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Stanford University 27
Testing effectiveness (Phase 2)UnknownNCT05399394
What this trial is testing

Induction FOLFIRINOX Followed by Chemoradiation in Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Campus Bio-Medico University 50
Next Page